<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the time interval between symptom <z:hpo ids='HP_0003674'>onset</z:hpo> and <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> related to <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> in patients with massive <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The time period between <z:hpo ids='HP_0003674'>onset</z:hpo> and <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> represents the window for surgical intervention </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Multicenter retrospective chart review </plain></SENT>
<SENT sid="3" pm="."><plain>SETTINGS: Five university-affiliated medical centers </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENTS: Fifty-three patients with massive <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> who experienced <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> defined by a decrease in the Glasgow <z:hpo ids='HP_0001259'>Coma</z:hpo> Scale score of two or more points attributable to mass effect </plain></SENT>
<SENT sid="5" pm="."><plain>MEASUREMENTS AND MAIN RESULTS: A total of 53 patients (mean age, 62 +/- 18 yrs; 25 [47%] were men) with <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> were identified by using International Classification of Diseases (9th revision) codes and local registries </plain></SENT>
<SENT sid="6" pm="."><plain>Medical records and neuroimaging studies were reviewed by a <z:hpo ids='HP_0001297'>stroke</z:hpo> neurologist or neurointensivist to identify the time of <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Thrombolytics were used at presentation in 19 (35%) patients </plain></SENT>
<SENT sid="8" pm="."><plain>A total of 19 (36%) patients had <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> within 24 hrs of symptom <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>By 48 hrs, 36 (68%) patients had manifested clinical deterioration </plain></SENT>
<SENT sid="10" pm="."><plain>A few patients had later <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> on day 3 (n = 10), day 4 (n = 2), day 5 (n = 2), and day 6 or after (n = 3) </plain></SENT>
<SENT sid="11" pm="."><plain>A total of 25 (47%) of the 53 patients died during hospitalization </plain></SENT>
<SENT sid="12" pm="."><plain>The highest frequency of <z:hpo ids='HP_0011420'>deaths</z:hpo> occurred on day 3 </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0002344'>Neurologic deteriorations</z:hpo> related to <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> after massive <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> occur in most patients within 48 hrs of symptom <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
</text></document>